CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 19016-19136 JSONTXT

Annnotations TAB JSON ListView MergeView

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/68a7101a90454172c91785d8c352f776a82df5d4","sourcedb":"CORD-19","sourceid":"68a7101a90454172c91785d8c352f776a82df5d4","text":"Interferon beta (IFNb) treatment is beneficial for a majority of Relapsing-Remitting Multiple Sclerosis (RRMS) patients.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T122","span":{"begin":0,"end":120},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T122","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T122","span":{"begin":0,"end":120},"obj":"Sentence"}],"attributes":[{"subj":"T122","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T25207","span":{"begin":65,"end":103},"obj":"Disease"},{"id":"T85966","span":{"begin":105,"end":109},"obj":"Disease"},{"id":"T31819","span":{"begin":65,"end":103},"obj":"Disease"},{"id":"T24804","span":{"begin":105,"end":109},"obj":"Disease"}],"attributes":[{"id":"A50569","pred":"mondo_id","subj":"T25207","obj":"http://purl.obolibrary.org/obo/MONDO_0005314"},{"id":"A85446","pred":"mondo_id","subj":"T85966","obj":"http://purl.obolibrary.org/obo/MONDO_0005314"},{"id":"A74765","pred":"mondo_id","subj":"T31819","obj":"http://purl.obolibrary.org/obo/MONDO_0005314"},{"id":"A35459","pred":"mondo_id","subj":"T24804","obj":"http://purl.obolibrary.org/obo/MONDO_0005314"},{"subj":"T25207","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T85966","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T31819","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T24804","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93d3ec","default":true},{"id":"CORD-19_Custom_license_subset","color":"#eceb93"},{"id":"CORD-19-PD-MONDO","color":"#d193ec"}]}]}}